Skip to main content
. 2017 Jul 5;2017(7):CD003414. doi: 10.1002/14651858.CD003414.pub3

Summary of findings 2. Natural cycle FET versus HT plus GnRHa suppression FET.

Natural cycle FET versus HT + GnRHa suppression FET
Population: subfertile women
 Settings: assisted reproductive technology clinics
 Comparison: HT + GnRHa FET
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
HT + GnRHa FET Natural cycle FET
Live birth rate per woman 316 per 1000 262 per 1000 
 (153 to 414) OR 0.77 
 (0.39 to 1.53) 159
 (1 study) ⊕⊕⊝⊝
 low1 Only 46 events
Miscarriage rate per woman No data available Not estimable    
Ongoing pregnancy rate per woman No data available Not estimable    
Multiple pregnancy rate per woman 63 per 1000 38 per 1000 
 (9 to 144) OR 0.58 
 (0.13 to 2.50) 159
 (1 study) ⊕⊕⊝⊝
 low1 Only 8 events
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: confidence interval; FET: frozen‐thawed embryo transfer; GnRHA: gonadotrophin‐releasing hormone agonist; HT: hormone therapy; OR: odds ratio
GRADE Working Group grades of evidenceHigh quality: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1Downgraded two levels due to very serious imprecision: single study, few events, confidence interval compatible with benefit in either group or with no effect.